Author

Shuchen Liu

Scripps Research InstituteORCID 0000-0003-4685-491XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:GWAS summary statistics· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Ahmed El-kallinyiD· 1 shared Ali TorkamaniiD· 1 shared André Nicolás LeóniD· 1 shared Arjun Ghoshal· 1 shared Bhavneet BhinderiD· 1 shared Bhuvan Molparia· 1 shared Brian Schrader· 1 shared Brianna Fernandez· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Ahmed El-kallinyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 22, 2024

The Orphan G Protein-Coupled Receptor GPR52 is a Novel Regulator of Breast Cancer Multicellular Organization

Sarah Z. Hanif, CheukMan Cherie Au, Ingrid Torregroza…·Kristy A. Brown

This study shows that loss of GPR52 in breast cancer cells increases cell clustering, EMT features, and tumor burden in zebrafish, suggesting GPR52 as a potential therapeutic target.

DOI 10.1101/2024.07.22.604482

zebrafishbulk RNA-seq

𝕏 PostBluesky

Genetic & Genomic Medicinenpj Digital MedicinePeer-reviewedMar 11, 2022

Response to Polygenic Risk: Results of the MyGeneRank Mobile Application-Based Coronary Artery Disease Study

Evan D. Muse, Shang‐Fu Chen, Shuchen Liu…·Ali Torkamani

This study evaluates the impact of coronary artery disease polygenic risk scores on lipid-lowering therapy initiation via a mobile application, finding higher therapy rates among high-risk individuals.

43 citationstop 1%

humanGWAS summary statistics

𝕏 PostBluesky